Literature DB >> 9243150

New diagnostic criteria for infective endocarditis. A study of sensitivity and specificity.

E Cecchi1, I Parrini, A Chinaglia, F Pomari, G Brusasco, M Bobbio, R Trinchero, A Brusca.   

Abstract

OBJECTIVE: The purpose of this study was to determine the sensitivity and specificity of new criteria proposed by Duke University for case definition of infective endocarditis as compared to the previously accepted Von Reyn criteria. PATIENTS: A total of 143 consecutive suspected cases of infective endocarditis in 137 febrile patients were included. Of these, 69 had infective endocarditis, pathologically proven in 28, but with only a clinical diagnosis in 41. In the remaining 74 cases, the diagnosis of infective endocarditis was rejected after a follow-up of at least 3 months.
RESULTS: The sensitivity of Duke's criteria was significantly higher, both when patients with possible infective endocarditis were considered as true-positive (definition 1; 100% vs 69%, P < 0.001) and when possible cases were considered as rejected (definition 2; 76% vs 51%, P < 0.01). Specificity was very high with both criteria: 92% Von Reyn vs 88% Duke (ns) with definition 1 and 99% Von Reyn vs 97% Duke (ns) with definition 2. The overall accuracy of the Duke criteria in the entire population was significantly higher with both definitions (0.94 vs 0.81 definition 1, P < 0.001; 0.87 vs 0.75, P = 0.015 definition 2).
CONCLUSION: Duke's criteria for defining infective endocarditis has been shown to be more sensitive than previously adopted criteria, while maintaining a high degree of specificity. Therefore, they must be accepted as a substitute for previous criteria.

Entities:  

Mesh:

Year:  1997        PMID: 9243150     DOI: 10.1093/oxfordjournals.eurheartj.a015411

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Echocardiography for the Diagnosis of Staphylococcus aureus Infective Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Infective endocarditis in Europe: lessons from the Euro heart survey.

Authors:  P Tornos; B Iung; G Permanyer-Miralda; G Baron; F Delahaye; Ch Gohlke-Bärwolf; E G Butchart; P Ravaud; A Vahanian
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 3.  Infective Endocarditis: A Focus on Oral Microbiota.

Authors:  Carmela Del Giudice; Emanuele Vaia; Daniela Liccardo; Federica Marzano; Alessandra Valletta; Gianrico Spagnuolo; Nicola Ferrara; Carlo Rengo; Alessandro Cannavo; Giuseppe Rengo
Journal:  Microorganisms       Date:  2021-06-04

4.  A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.

Authors:  Shahid Husain; Martha L Mooney; Lara Danziger-Isakov; Frauke Mattner; Nina Singh; Robin Avery; Michael Ison; Atul Humar; Robert F Padera; Leo P Lawler; Andy Fisher; Richard J Drew; Kate F Gould; Amparo Sole; Sean Studer; Patricia Munoz; Lianne G Singer; Margaret Hannan
Journal:  J Heart Lung Transplant       Date:  2011-04       Impact factor: 10.247

5.  Assesment of the Duke criteria for the diagnosis of infective endocarditis after twenty-years. An analysis of 241 cases.

Authors:  Adriana Topan; Dumitru Carstina; Adriana Slavcovici; Raluca Rancea; Radu Capalneanu; Mihaela Lupse
Journal:  Clujul Med       Date:  2015-07-01

6.  Successful treatment of acute renal failure secondary to complicated infective endocarditis by peritoneal dialysis: a case report.

Authors:  Aisha M Al-Osail; Ibrahim M Al-Zahrani; Abdullah A Al-Abdulwahab; Sarah M Alhajri; Emad M Al-Osail; Abdullah K Al-Hwiesh; Fahad A Al-Muhanna
Journal:  BMC Res Notes       Date:  2017-09-07

7.  ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task force I: direct cardiovascular implications of emerging infectious diseases and biological terrorism threats.

Authors:  Larry M Baddour; Zhi-Jie Zheng; Darwin R Labarthe; Siobhán O'Connor
Journal:  J Am Coll Cardiol       Date:  2007-03-27       Impact factor: 24.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.